All-Inclusive Medical Package
A bundled pricing arrangement that covers the procedure, hospital stay, meals, translation services, airport transfers, and coordination fees in a single quoted price. Reduces financial uncertainty for international patients.
Bilateral Medical Visa (Medical Tourist Visa)
A visa category issued by Chinese embassies specifically for patients travelling to China for medical treatment. Typically requires a letter of invitation from the treating hospital.
Bilingual Coordinator
An English- and Mandarin-speaking medical professional who accompanies international patients throughout their treatment journey. Translates medical conversations, coordinates with hospital staff and surgeons, and ensures the patient fully understands every step. SinoRX provides a dedicated bilingual coordinator for every patient.
Dental Implant
A titanium post surgically placed into the jawbone to replace a missing tooth root, onto which a crown is attached. In China, full-arch dental implant procedures (replacing all teeth) cost 60–70% less than equivalent treatment in the UK or US.
Discharge Summary
A clinical document prepared by the treating hospital at the end of a patient’s stay. Includes diagnosis, procedures performed, medications prescribed, and follow-up instructions. Essential for continuity of care with the patient’s home doctor.
Executive Health Screening
A comprehensive medical check-up covering cardiovascular, oncological, metabolic, and other key health domains. Typically includes 60+ blood markers, CT or MRI imaging, cardiac evaluation, and specialist consultations. At Grade 3A hospitals in China, executive screenings cost $500–$900, compared to $2,500–$5,000 in the US.
Fudan University Hospital Rankings
An authoritative annual ranking of Chinese hospitals by specialty, published by Fudan University’s Institute of Hospital Management. Used to identify the top hospital in China for a given clinical specialty — e.g., Jishuitan #1 for orthopedics, Beijing Tongren #1 for ophthalmology, Peking University School of Stomatology #1 for dentistry.
Grade 3A Hospital(三甲医院)
China’s highest hospital classification, awarded by the National Health Commission. Only approximately 1,500 of China’s 35,000+ hospitals hold this designation. Grade 3A hospitals must meet strict standards for staffing, equipment, research output, and patient outcomes. SinoRX exclusively partners with Grade 3A institutions.
Hip Replacement (Total Hip Arthroplasty)
A surgical procedure in which a damaged hip joint is replaced with an artificial implant. In China, the procedure costs approximately $8,000–$15,000 all-inclusive, compared to $30,000–$50,000 in the US.
Knee Replacement (Total Knee Arthroplasty)
A surgical procedure in which a damaged knee joint is replaced with an artificial implant. In China, total knee replacement at Grade 3A orthopedic centres costs approximately $7,500–$14,000 all-inclusive, compared to $30,000–$40,000 in the US.
LASIK (Laser-Assisted In Situ Keratomileusis)
A laser eye surgery procedure that reshapes the cornea to correct refractive errors including short-sightedness, long-sightedness, and astigmatism. LASIK in China at Grade 3A hospitals typically costs $1,500–$2,500 for both eyes, compared to $4,000–$5,000 in the US.
Medical Concierge
A personal coordination service that manages every logistical aspect of a patient’s medical journey, including hospital selection, appointment scheduling, translation, accommodation, and post-treatment follow-up. SinoRX operates as a medical concierge for international patients travelling to China.
Medical Tourism
The practice of travelling to another country to receive medical treatment, typically to access lower costs, shorter waiting times, or specialist expertise not available domestically.
Remote Follow-Up
Post-treatment consultations conducted via video call or messaging between the patient (now at home) and the treating physician or SinoRX coordinator. Covers wound checks, medication adjustments, and recovery milestones.
Volume-Based Procurement (VBP)(集采)
A Chinese government policy that negotiates pharmaceutical and medical device prices directly with manufacturers at national scale. Implemented across multiple device categories from 2023, VBP cut dental-implant prices by approximately 55% nationwide and is a key structural reason China’s medical costs are lower than the US, UK, or Australia.